Individuals Coming Off Anti-Obesity Jabs Regain Weight Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that individuals who discontinue popular GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end conventional lifestyle programs.

Findings released in a leading medical journal demonstrates that while obese individuals can lose a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing such drugs should be cognizant of the danger of fast weight regain when the therapy ends," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a return to original mass within about 18 months.

Comparing Approaches

The research, which looked at dozens of studies involving thousands of patients, contrasted the outcomes of these new drugs with conventional dieting.

The team note that people who shed pounds through diet and exercise usually see a less rapid creep back—approximately 0.1 kg a month—after stopping.

Understanding the Fast Rebound

Doctors suggest the mechanism of the injections explains the heightened regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of the hormone levels several times higher than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication means appetite is uncontrolled, making overeating a significant risk."

A Chronic Issue?

The NHS suggest the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Professionals contend that, due to the high risk of relapse, the treatment is often life-long.

This view is supported by drug manufacturers, who say that the results "highlight the chronic nature of obesity," comparing it to managing conditions like hypertension.

User Accounts

Users who have stopped the jabs describe a sudden return of appetite.

"It felt as if a switch that goes on and you become ravenous," said a patient.

This challenge is compounded if individuals have not established sustainable dietary or behavioural modifications during therapy.

Widespread Interest

Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Use is more common among females compared to men.
• The middle-aged age group shows the greatest level of interest.
• Many obtain the medications through private prescriptions rather than the NHS.

Ultimately, researchers stress that while the jabs are powerful tools for weight loss, they are not a permanent fix and lasting health benefits relies on combined behavioural support.